Outset Medical, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights – OM

Core Viewpoint - The Gross Law Firm is notifying shareholders of Outset Medical, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions related to the company's Tablo products during the specified class period [1][2]. Group 1: Allegations - The complaint alleges that Outset Medical made materially false and/or misleading statements regarding its Tablo products, which are primarily used in dialysis care [2]. - It is claimed that the Tablo products were marketed for continuous renal replacement therapy, an indication not approved by the FDA, leading to potential regulatory issues [2]. - The company is said to have lacked the necessary sales team and processes to effectively ramp up Tablo sales, which would adversely impact revenue growth [2]. Group 2: Class Action Details - The class period for the lawsuit is defined as August 1, 2022, to August 7, 2024, with a deadline for shareholders to register by October 28, 2024 [2][3]. - Shareholders who register will be enrolled in a portfolio monitoring software to receive updates on the case's status [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].